{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:11Z","timestamp":1786120391769,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/iae.0b013e31824b824c","type":"journal-article","created":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T05:49:14Z","timestamp":1333604954000},"page":"1853-1861","source":"Crossref","is-referenced-by-count":11,"title":["DISRUPTED FOVEAL PHOTORECEPTORS AFTER COMBINED CYSTOID SPACES AND RETINAL DETACHMENT IN BRANCH VEIN OCCLUSION TREATED WITH BEVACIZUMAB"],"prefix":"10.1097","volume":"32","author":[{"given":"Tomoaki","family":"Murakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitaka","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Kurashige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagahisa","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-21-20210130","first-page":"271","article-title":"The Branch Vein Occlusion Study Group.","volume":"98","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"R3-21-20210130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.88.1.154","article-title":"Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion.","volume":"88","author":"Chen","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R4-21-20210130","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archophthalmol.2009.233","article-title":". A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 6.","volume":"127","author":"Scott","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R5-21-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199901000-00001","article-title":"Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases.","volume":"19","author":"Opremcak","year":"1999","journal-title":"Retina"},{"key":"R6-21-20210130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1023\/A:1002432032354","article-title":"Vitrectomy for macular edema combined with retinal vein occlusion.","volume":"97","author":"Tachi","year":"1999","journal-title":"Doc Ophthalmol"},{"key":"R7-21-20210130","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/00006982-200212000-00009","article-title":"Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion.","volume":"22","author":"Mester","year":"2002","journal-title":"Retina"},{"key":"R8-21-20210130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ophtha.2007.01.010","article-title":"Interventions for branch retinal vein occlusion: an evidence-based systematic review.","volume":"114","author":"McIntosh","year":"2007","journal-title":"Ophthalmology"},{"key":"R9-21-20210130","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":". Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"R10-21-20210130","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":". Pegaptanib for neovascular age-related macular degeneration.","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"key":"R11-21-20210130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ajo.2005.03.003","article-title":". Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6.","volume":"140","author":"Noma","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R13-21-20210130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-200603000-00005","article-title":". Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.","volume":"26","author":"Iturralde","year":"2006","journal-title":"Retina"},{"key":"R14-21-20210130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/IAE.0b013e3181619bee","article-title":". Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up.","volume":"28","author":"Wu","year":"2008","journal-title":"Retina"},{"key":"R15-21-20210130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bjo.2008.141085","article-title":". Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial.","volume":"93","author":"Prager","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R16-21-20210130","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":". Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"key":"R17-21-20210130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9394(01)01269-7","article-title":". Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema.","volume":"133","author":"Funatsu","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R18-21-20210130","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00417-008-0866-8","article-title":". Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion.","volume":"246","author":"Chung","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R19-21-20210130","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.ophtha.2010.03.060","article-title":". Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes.","volume":"117","author":"Campochiaro","year":"2010","journal-title":"Ophthalmology"},{"key":"R20-21-20210130","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1126\/science.1957169","article-title":". Optical coherence tomography.","volume":"254","author":"Huang","year":"1991","journal-title":"Science"},{"key":"R21-21-20210130","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0002-9394(99)00033-1","article-title":"Patterns of diabetic macular edema with optical coherence tomography.","volume":"127","author":"Otani","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R22-21-20210130","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ophtha.2008.10.017","article-title":". SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.","volume":"116","author":"Scott","year":"2009","journal-title":"Ophthalmology"},{"key":"R23-21-20210130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00006982-200306000-00009","article-title":"Optical coherence tomography of branch retinal vein occlusion.","volume":"23","author":"Spaide","year":"2003","journal-title":"Retina"},{"key":"R24-21-20210130","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.ophtha.2004.04.031","article-title":". Delayed absorption of macular edema accompanying serous retinal detachment after grid laser treatment in patients with branch retinal vein occlusion.","volume":"111","author":"Ohashi","year":"2004","journal-title":"Ophthalmology"},{"key":"R25-21-20210130","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1167\/iovs.04-1383","article-title":"The association between visual acuity and central retinal thickness in retinitis pigmentosa.","volume":"46","author":"Sandberg","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-21-20210130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ajo.2006.08.030","article-title":". Photoreceptor status after resolved macular edema in branch retinal vein occlusion treated with tissue plasminogen activator.","volume":"143","author":"Murakami","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R27-21-20210130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajo.2007.09.019","article-title":". Foveal photoreceptor layer in eyes with persistent cystoid macular edema associated with branch retinal vein occlusion.","volume":"145","author":"Ota","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R29-21-20210130","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00417-009-1107-5","article-title":". Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy.","volume":"247","author":"Sakamoto","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R30-21-20210130","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1442-9071.2009.01914.x","article-title":". Evaluation of potential visual acuity in eyes with macular oedema secondary to retinal vein occlusion.","volume":"37","author":"Sakamoto","year":"2009","journal-title":"Clin Experiment Ophthalmol"},{"key":"R31-21-20210130","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10384-010-0878-x","article-title":". Visual acuity following intravitreal bevacizumab for macular edema associated with retinal vein occlusion.","volume":"54","author":"Ota","year":"2010","journal-title":"Jpn J Ophthalmol"},{"key":"R32-21-20210130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ophtha.2010.03.035","article-title":". Foveal cystoid spaces are associated with enlarged foveal avascular zone and microaneurysms in diabetic macular edema.","volume":"118","author":"Murakami","year":"2011","journal-title":"Ophthalmology"},{"key":"R33-21-20210130","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0161-6420(88)33001-0","article-title":"Cystoid macular degeneration in experimental branch retinal vein occlusion.","volume":"95","author":"Wallow","year":"1988","journal-title":"Ophthalmology"},{"key":"R34-21-20210130","doi-asserted-by":"crossref","first-page":"10242","DOI":"10.1073\/pnas.97.18.10242","article-title":"Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia.","volume":"97","author":"Jin","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R35-21-20210130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/88842","article-title":". Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.","volume":"28","author":"Oosthuyse","year":"2001","journal-title":"Nat Genet"},{"key":"R36-21-20210130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature02544","article-title":". VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.","volume":"429","author":"Azzouz","year":"2004","journal-title":"Nature"},{"key":"R37-21-20210130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0161-6420(98)93020-2","article-title":". Vascular endothelial growth factor upregulation in human central retinal vein occlusion.","volume":"105","author":"Peer","year":"1998","journal-title":"Ophthalmology"},{"key":"R38-21-20210130","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/archopht.1992.01080220089028","article-title":"Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion.","volume":"110","author":"Finkelstein","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"R39-21-20210130","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0161-6420(82)34698-9","article-title":"Pathology of cystoid macular edema.","volume":"89","author":"Tso","year":"1982","journal-title":"Ophthalmology"},{"key":"R40-21-20210130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0039-6257(84)90233-9","article-title":"Pathology of human cystoid macular edema.","volume":"28","author":"Yanoff","year":"1984","journal-title":"Surv Ophthalmol"},{"key":"R41-21-20210130","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archopht.1982.01030040110020","article-title":"Histopathologic study of nine branch retinal vein occlusions.","volume":"100","author":"Frangieh","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"R42-21-20210130","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0002-9394(81)90638-3","article-title":"Macular edema and cystoid macular edema.","volume":"92","author":"Fine","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"R43-21-20210130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00417-009-1167-6","article-title":". Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion.","volume":"248","author":"Ach","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R44-21-20210130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2337\/diabetes.50.2.444","article-title":". Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension.","volume":"50","author":"Suzuma","year":"2001","journal-title":"Diabetes"},{"key":"R45-21-20210130","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI2425","article-title":". Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.","volume":"102","author":"Barber","year":"1998","journal-title":"J Clin Invest"},{"key":"R46-21-20210130","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/bjo.59.11.649","article-title":"Early breakdown of the blood-retinal barrier in diabetes.","volume":"59","author":"Cunha-Vaz","year":"1975","journal-title":"Br J Ophthalmol"},{"key":"R47-21-20210130","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archopht.1961.00960010368014","article-title":"Retinal vascular patterns. IV. Diabetic retinopathy.","volume":"66","author":"Cogan","year":"1961","journal-title":"Arch Ophthalmol"},{"key":"R48-21-20210130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0002-9394(70)92273-7","article-title":"Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy.","volume":"69","author":"Kohner","year":"1970","journal-title":"Am J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006982-201210000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:43:36Z","timestamp":1786049016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201210000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e31824b824c","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}